ACADIA Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACAD and other ETFs, options, and stocks.About ACAD
ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.
ACAD Key Statistics
ACAD News
Deutsche Bank lowered the firm’s price target on Acadia Pharmaceuticals (ACAD) to $29 from $35 and keeps a Buy rating on the shares. Elevate Your Investing Str...
TD Cowen analyst Ritu Baral maintained a Buy rating on ACADIA Pharmaceuticals today and set a price target of $35.00. Elevate Your Investing Strategy: Take adva...
Acadia Pharmaceuticals Inc. ACAD released topline results on Wednesday from its Phase 3 COMPASS PWS trial evaluating the efficacy and safety of intranasal carbe...
Analyst ratings
63%
of 19 ratingsMore ACAD News
Ami Fadia, an analyst from Needham, reiterated the Buy rating on ACADIA Pharmaceuticals. The associated price target was lowered to $28.00. Elevate Your Investi...
Analyst Sean Laaman of Morgan Stanley maintained a Hold rating on ACADIA Pharmaceuticals, retaining the price target of $24.00. Elevate Your Investing Strategy:...